Archives

Jerry Katzman, M.D., CEO of Intubation Science Inc.

Precision Under Pressure: Intubation Science's Innovative Solution for Life-Saving Intubations

We have all watched the tense ER scenes play out in our favorite medical dramas. The team of nurses and doctors rush to intubate a patient with respiratory failure. The tension builds as the doctor tries to carefully navigate the tube down the trachea as time runs out for the patient. If it goes as planned, the scene ends with the steady hiss of a ventilator. No hiss-well, you know the ending.


Godmother of AI' Fe-Fei Li Secures $1B Valuation for New Startup, World Labs

Fei-Fei Li’s AI startup, World Labs, raised $230 million in funding, valuing the company at over $1 billion as it prepares to develop AI models for 3D interaction by 2025.

Starlink to Provide Free In-Flight Internet Across United Airlines Fleet Starting 2025

United Airlines and Starlink have teamed up to offer free, high-speed in-flight internet on over 1,000 aircraft starting in early 2025, enhancing passenger connectivity with features like live TV and streaming services.

Wealthy Families Rush to Transfer Millions to Children Over Fear of Kamala Harris' Tax Policies

Wealthy families are rushing to transfer assets to their children before potential estate tax increases if Kamala Harris wins the presidency and current exemptions expire in 2025.


Latest News

Federal Cleanup Crew Spills 3 Million Gallons Of Toxic Mine Waste In Colorado's Animas River
CJK Milling plans to extract more gold from old mining waste in Leadville, Colorado, but residents worry that it could worsen pollution and undo years of cleanup efforts.
Joe Biden's Meeting With Xi Jinping Could Reduce Uncertainty for US-China Businesses, Analysts Say
A proposed U.S. bill, HKETO, could lead to the shutdown of Hong Kong's trade offices if they are deemed too influenced by China, drawing strong objections from Beijing.
Chris Webber
These 14-minute talks, featuring influential figures like Bill Gates and Greta Thunberg, have captivated audiences worldwide with their potent blend of stories, images, and succinct messages. But what is it about the TED format that makes it so compelling? And why aren't more business meetings following suit? Enter Foxleigh Commercial Performance, a company dedicated to revolutionising the way businesses conduct meetings.
US Inflation Falls to Lowest Since Early 2021, But Consumer Prices Remain High
In August, the CPI rose 0.2%, keeping inflation at 2.5%, its lowest since 2021, while traders anticipate an interest rate cut from the Federal Reserve.
The Town of Celebration
Low-income families with children who rely on free school lunches are complaining about hidden digital payment fees that cost at least $2 per school lunch.
ABC News Hosts Presidential Debate Between Donald Trump And VP Kamala Harris At The National Constitution Center In Philadelphia
Donald Trump's company suffered a 15% share decline following last night's presidential debate, just after betting odds for Kamala Harris increased.
Ethos Network Introduces Credibility Scores to Clean Up Crypto
"75% of Americans who have heard of cryptocurrencies are not confident in their safety and reliability," concluded a 2023 Pew Research survey. Decentralized credibility platform Ethos is on a mission to change that by building on the proof-of-stake concept but adapting its 'Proof of Credibility' to social interactions to address the pervasive issue of trust and accountability in the crypto space.
SpaceX's Historic Private Spacewalker is Billionaire Jared Isaacman—Will They Beat Apollo's Distance?
SpaceX's first private spacewalk mission, led by billionaire Jared Isaacman, aims to surpass past space records with a five-day flight that includes testing custom spacesuits while venturing farther than the International Space Station.
APPLE-SINGAPORE
Ireland is set to receive a €13 billion ($14 billion) tax payment from Apple after an EU court ruling, despite Apple's objections and Ireland's reluctance to collect the back taxes.
AstraZeneca, Daiichi Sankyo's Experimental Drug Dato-DXd Shows Promise in Extending Life for Some Lung Cancer Patients
AstraZeneca’s shares fell over 5% following disappointing results from its TROPION-Lung01 Phase III trial, which showed its experimental lung cancer drug did not improve survival rates.
  20 21 22 23 24 25 26 27 28  
Real Time Analytics